other material
confidence high
sentiment neutral
materiality 0.25
Zymeworks reports annual meeting results and amends director compensation policy
Zymeworks Inc.
- Elected four directors with 82-99% votes for; KPMG ratified as auditor with 96.86% votes for.
- Advisory vote on named executive officer compensation approved with 93.33% votes for.
- Board increased R&D committee retainer from $6,000 to $7,500 effective Jan 1, 2025.
- Initial option grant for new directors reduced from 74k to 62k shares; annual grant from 37k to 31k.